Skip to main content

Overview

Dr. Harsimran Singh grew up in Lancaster, Pennsylvania, earning his undergraduate education in Molecular Biology from Princeton University. He traveled abroad to complete a Masters in Health Care Policy at the London School of Hygiene & Tropical Medicine. He received his medical degree from Yale University School of Medicine. He completed his internship and residency training in Internal Medicine at University of California, San Francisco. He then returned back east to complete his fellowship training and board certification in both Cardiovascular Diseases and Interventional Cardiology from Columbia University – New York Presbyterian Hospital. Finally, he obtained specialized training in Adult Congenital Heart Disease and Structural Interventional Cardiology in Canada at Toronto General Hospital & The Hospital for Sick Children. He has now joined the full-time faculty at Weill Cornell Medical College – New York Presbyterian Hospital as a specialist in Adult Congenital Heart Disease and Interventional Cardiology.

As an interventional cardiologist, Dr. Singh performs percutaneous interventions for coronary artery and valvular disease from both a femoral and radial approach. He has considerable clinical experience in performing percutaneous interventions in adults with congenital and structural heart defects. He has an active clinical cardiology practice that includes patients with both acquired and congenital cardiac conditions. Dr. Singh also speaks Hindi, Punjabi, and Spanish.

Highlights

  1. 1
    Pulmonary circulation · 2024
    PMID: 38736894PMCID: PMC11082429DOISenior author4 citations
  2. 2
    Heart (British Cardiac Society) · 2022
    PMID: 36261281DOISenior author6 citations
  3. 3
    Circulation · 2020
    PMID: 32255370PMCID: PMC7302091DOISenior author4 citations

Publications

88 publications

Funding

2 grants

Active

1 grant
  • Co-I
    The HOPE (Heart Outcomes in Pregnancy: Expectations) for Mom and Baby Study
    National Heart, Lung, and Blood Institute · 2024–2028 · via University of Missouri· 2 renewals
    R01HL166836-01A1
Completed grants (1)
  • Co-I
    Utilizing PCORnet to support transition from pediatric to adult centered care and reduce gaps in recommended care in patients with congenital heart disease.
    Patient-Centered Outcomes Research Institute · 2021–2024 · via Louisiana Public Health Institute
    RD-2020C2-20347

Clinical research

4 studies
Completed & closed trials (4)
  • PI
    Utilizing PCORnet to Support Transition From Pediatric to Adult Centered Care and Reduce Gaps in Recommended Care in Patients With Congenital Heart Disease
    Patient-Centered Outcomes Research Institute · CLOSED TO ACCRUAL (as of 2023)
    Congenital Heart Disease; Comorbidities and Coexisting Conditions
    NCT05185232
  • PI
    Pre-procedural ANxiety In Congenital Heart Disease (PANIC)
    Spectrum Health · IRB STUDY CLOSURE (as of 2022)
  • PI
    STITCH - Prospective Multi Center Comparative Parallel Concurrent Study of the NobleStitch EL Compared to FDA Approved Amplatzer Occluder Device for Closure of Patent Foramen Ovale to Prevent Recurrent Ischemic Stroke
    NA · Nobles Medical Technologies II, Inc. · IRB STUDY CLOSURE (as of 2022)
    Foramen Ovale, Patent; Stroke, Ischemic
    NCT04339699
  • PI
    COVID-19 in Adults with Congenital Heart Disease
    University of California, Los Angeles · CLOSED TO ACCRUAL (as of 2021)

News mentions

External relationships

Advisory/Scientific Board Member

McGraw-Hill Education

Other

Abbott Cardiovascular Systems, Inc.